Search for: "Par Pharmaceutical Holdings, Inc."
Results 1 - 20
of 53
Sorted by Relevance
|
Sort by Date
27 Jan 2014, 9:47 am
("Par Pharmaceutical Companies") and Par Pharmaceutical, Inc. [read post]
5 Sep 2011, 9:36 pm
TWi Pharmaceuticals, Inc. 1:11-cv-02466; filed September 1, 2011 in the District Court of Maryland • Plaintiffs: Par Pharmaceutical, Inc.; EDT Pharma Holdings Ltd. [read post]
14 Aug 2011, 9:59 pm
Par Pharmaceutical Inc. et al. 1:11-cv-00705; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
4 Dec 2014, 10:00 pm
In Par Pharmaceutical Inc. v. [read post]
3 Sep 2018, 9:16 pm
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
19 Apr 2012, 8:17 pm
AR Holding Co. [read post]
29 Nov 2015, 9:54 pm
• Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical, Inc. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
20 May 2015, 1:00 am
Wall Street Journal, Rules Fail To Rein In Tax-Driven Takeovers: Endo International PLC agreed to buy rival drug maker Par Pharmaceutical Holdings Inc. for $8 billion, the latest in a string of cross-border mergers steering tax revenue away from the U.S., despite Washington’s efforts. [read post]
16 Sep 2021, 12:57 pm
Suffolk and Nassau Counties will each receive $13.85 million in combined settlements from Endo and its subsidiary Par Pharmaceutical, Inc. [read post]
30 Sep 2013, 8:12 am
District Court for the District of Delaware against Apotex Corp.; Hetero USA Inc.; Lupin Ltd.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
14 Jun 2010, 6:12 pm
Par Pharm., Inc., 642 F. [read post]
2 Dec 2009, 11:05 am
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical… [read post]
13 Jul 2018, 1:57 pm
We hold otherwise. [read post]
7 Feb 2013, 10:50 am
Par Pharmaceutical, Inc., 694 F.3d 1344, 1351 (Fed. [read post]
10 Oct 2014, 1:16 pm
JHP Pharmaceuticals, LLC v. [read post]
22 Apr 2009, 6:14 am
Citigroup has been hit with a $30 million auction-rate securities lawsuit filed by Braintree Laboratories, Inc., a specialty pharmaceutical company, reported Christine Caufield in an April 17, 2009 article posted on Law360.com. [read post]
3 Nov 2014, 9:48 am
Hospira, Inc.,[2] Par Sterile Products (formerly JHP Pharmaceuticals), a manufacturer of ADRENALIN, an FDA-approved injectable epinephrine product, brought Lanham Act claims against several defendants, American Regent Inc., Hospira Inc. and International Medical Systems, Ltd. [read post]
